Avalyn Pharma Inc is a clinical-stage biopharmaceutical company developing inhaled medicines to treat rare respiratory diseases, including pulmonary fibrosis and other interstitial lung diseases… Avalyn Pharma is based in Boston, MA and was founded in 2011. It is valued at about $155 million as of Oct 2026, set by institutional fund marks. It has raised $387 million.
PMV mark · valuation
$155.0M
Oct 2026
Priced at
—
Total raised
$386.7M
Last round
—
Team — not yet on record
No current team members for Avalyn Pharma are on record yet. People surface from round filings, company disclosures, and coverage sessions.
Pro members can request priority coverage with a 48-hour turnaround.
Free account
More of Avalyn Pharma with a free account
·The complete investor list: 28 names
·Watch Avalyn Pharma: the Monday email on marks, rounds and moves
